PUBLISHER: The Business Research Company | PRODUCT CODE: 1829222
PUBLISHER: The Business Research Company | PRODUCT CODE: 1829222
Craniomaxillofacial (CMF) surgery specializes in treating skull and facial disorders, particularly addressing severe cranial and facial bone injuries.
The primary products in the craniomaxillofacial (CMF) devices and equipment market include cranial flap fixation, CMF distraction devices, temporomandibular joint replacement solutions, thoracic fixation tools, MF plates, screw fixation sets, and other related equipment. Cranial flap fixation involves securing the flap using absorbable sutures packed tightly around bone shims in the surrounding area. These devices are crafted from various materials such as metal alloys and polymers, catering to neurosurgery, ENT, orthognathic and dental surgery, plastic surgery, and other related fields. They find application across hospital and ambulatory surgical center settings.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The sharp increase in U.S. tariffs and resulting trade tensions in spring 2025 are significantly impacting the medical equipment sector, especially for imported components used in imaging machines, surgical-grade stainless steel, and disposable plastics. With hospitals and clinics pushing back against price increases, manufacturers are facing margin pressure. The situation is further complicated by regulatory challenges, as switching suppliers due to tariffs often necessitates re-certification of medical devices, leading to delays in market entry. In response, companies are mitigating risks by dual-sourcing key components, ramping up domestic production of standardized items, and accelerating research into more cost-effective materials.
The craniomaxillofacial (CMF) devices and equipment market research report is one of a series of new reports from The Business Research Company that provides craniomaxillofacial (CMF) devices and equipment market statistics, including craniomaxillofacial (CMF) devices and equipment industry global market size, regional shares, competitors with a craniomaxillofacial (CMF) devices and equipment market share, detailed craniomaxillofacial (CMF) devices and equipment market segments, market trends and opportunities, and any further data you may need to thrive in the craniomaxillofacial (CMF) devices and equipment industry. This craniomaxillofacial (CMF) devices and equipment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The craniomaxillofacial (cmf) devices and equipment market size has grown strongly in recent years. It will grow from $1.97 billion in 2024 to $2.12 billion in 2025 at a compound annual growth rate (CAGR) of 7.6%. The growth in the historic period can be attributed to rapid growth in elderly population, increased number of accidents, increased healthcare expenditure, growth in the number of healthcare facilities, and economic growth in emerging markets.
The craniomaxillofacial (cmf) devices and equipment market size is expected to see strong growth in the next few years. It will grow to $2.86 billion in 2029 at a compound annual growth rate (CAGR) of 7.8%. The growth in the forecast period can be attributed to rising incidents of road accidents, a rise in sports-related injuries, increasing incidences of occupational accidents and improving healthcare facilities. Major trends in the forecast period include focus on artificial intelligence (AI), focus on 3d printing technology, focus on patient specific implants and focus on use integrated robotics and digital health technologies.
The forecast of 7.8% growth over the next five years reflects a modest reduction of 1.0% from the previous estimate for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through tariffs on biodegradable plating systems and orbital reconstruction guides, sourced from key regions such as Austria and Denmark, which could lead to reduced facial trauma treatment options and higher surgical costs for complex reconstructions.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.
The growing demand for reconstructive and cosmetic surgeries is anticipated to drive the expansion of the craniomaxillofacial (CMF) devices and equipment market in the coming years. Reconstructive surgeries are conducted to correct deformities caused by birth defects, trauma, or medical conditions, such as cancer, while cosmetic surgeries focus on enhancing appearance by reshaping and adjusting normal anatomy for a more visually appealing look. CMF devices play a key role in improving cosmetic appearance by aiding in the reshaping and adjustment of normal anatomy. For example, in September 2023, the International Society of Aesthetic Plastic Surgery, a US-based organization, reported that in 2022, plastic surgeons performed over 14.9 million surgical and 18.8 million non-surgical procedures globally, reflecting an 11.2% overall increase. Thus, the rising demand for reconstructive and cosmetic surgeries is propelling growth in the CMF devices and equipment market.
The increasing demand for minimally invasive surgeries is anticipated to drive the growth of the craniomaxillofacial (CMF) devices and equipment market in the future. Minimally invasive surgeries involve performing medical procedures through small incisions rather than larger ones. CMF devices play a crucial role in restoring aesthetics, functionality, and structural integrity to the craniofacial region, enabling patients to regain their normal oral functions, facial appearance, and overall quality of life. For example, in August 2023, The Aesthetic Society, a US-based organization focused on plastic surgery and cosmetic medicine, reported that Americans spent over $11.8 billion on aesthetic procedures, reflecting a 2% increase from the previous year. Thus, the rising demand for minimally invasive surgeries is propelling the growth of the craniomaxillofacial (CMF) devices and equipment market.
The utilization of 3D printing technology is becoming increasingly prominent in the craniomaxillofacial (CMF) devices and equipment market. 3D printing involves the creation of complex structures by layering thin materials on top of each other and shaping intricate edges. This technology is particularly beneficial in cranial and maxillofacial reconstructive surgery, where the use of 3D biomedical models proves highly advantageous. These 3D models play a crucial role in preoperative planning through advanced 3D modeling techniques. For example, Renishaw, a company in the field, has produced laser implants that are 3D-printed metal CMF patient-specific implants, exhibiting high strength and flexibility.
Leading companies in the Craniomaxillofacial (CMF) Devices and Equipment market are concentrating on developing technologically advanced solutions, such as surgical solutions, to enhance precision, improve patient outcomes, and streamline surgical procedures. Surgical solutions encompass specialized medical products, techniques, or technologies intended to facilitate effective and safe surgical procedures. These solutions may include instruments, devices, and systems that assist in diagnosis, treatment, and recovery, such as minimally invasive tools, imaging systems, and surgical implants. For example, in February 2024, Materialise NV, a Belgium-based 3D printing company, introduced the TMJ Total Arthroplasty System to address patients needing total temporomandibular joint (TMJ) arthroplasty. This system offers significant advantages, including a fully personalized treatment approach that enhances surgical precision and patient outcomes, as demonstrated by a reported 100% success rate one year after surgery. Furthermore, patients experience significant improvements in quality of life, pain levels, and functional abilities, such as eating, with accurate implant placement achieved in 97% of cases.
The EU Medical Devices Regulation has replaced two prior directives, with the implementation of new regulations set to conclude within three years after the transition period ended in 2020. Craniomaxillofacial (CMF) devices and equipment fall under the medical devices listed in the EU Medical Devices Regulations. Manufacturers of CMF devices and equipment are required to maintain a unique device identity to enhance device traceability. This mandate includes aesthetic devices that share similar characteristics and risk profiles with analogous medical devices. Furthermore, the management system standard for medical devices, ISO 13485, has been updated in alignment with the regulation. Manufacturers are also directed to provide implant cards for every implant medical device, containing comprehensive information about the respective device.
Major companies operating in the craniomaxillofacial (CMF) devices and equipment market include Johnson & Johnson, Stryker Corporation, Medtronic Plc, Zimmer-Biomet, Integra Lifesciences Corporation, KLS Martin L. P, B. Braun, Medartis AG, Matrix Surgical USA, Acumed, Roche India Pvt Ltd, Abbott India Limited, bioMerieux India, Becton Dickinson Private Limited, Danaher Corporation, Simens Healthcare, Beckman Coulter Inc India, Ortho Clinical Diagnostics, Bio-Rad Laboratories Inc, Sysmex Corporation, Thermo Fisher Scientific Inc, Asymchem, Sino Biological, ACROBiosystems, QPS, Wuxi Biologics, Qiagen Pvt Ltd, INVACARE POIRIER Fondettes, ESSILOR INTERNATIONAL Charenton-le-Pont, TERUMO FRANCE SAS Guyancourt, CAREFUSION FRANCE 309 SAS Le Pont-de-Claix, TOURLAVILLE DISTRIBUTION Cherbourg-Octeville, HARMONIE MEDICAL SERVICE Saint-Benoit, Balton, HTL-Strefa, TZMO, Consultronix, Kelyniam Global Inc, AbbVie Corporation, ABK Biomedical, Acart Equipment Ltd, A.R. Medicom Inc, Delphos Implants, Osteomed, Anatomics Pty Ltd, Bioplate Inc., Calavera Surgical Design, Innovasis.
North America was the largest region in the global craniomaxillofacial (CMF) devices and equipment market in 2024. Western Europe was the second-largest region in the global craniomaxillofacial (CMF) devices and equipment market. The regions covered in the craniomaxillofacial (CMF) devices and equipment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
The countries covered in the craniomaxillofacial (CMF) devices and equipment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Canada, Spain
The craniomaxillofacial (CMF) devices and equipment market consist of sales of plate and screw fixation devices, flap fixation devices, distraction systems, and temporomandibular joint (TMI) replacement devices. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Craniomaxillofacial (CMF) Devices And Equipment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on craniomaxillofacial (cmf) devices and equipment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for craniomaxillofacial (cmf) devices and equipment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The craniomaxillofacial (cmf) devices and equipment market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.